1. Home
  2. AMRX vs CNS Comparison

AMRX vs CNS Comparison

Compare AMRX & CNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

N/A

Current Price

$13.20

Market Cap

4.0B

Sector

Health Care

ML Signal

N/A

Logo Cohen & Steers Inc

CNS

Cohen & Steers Inc

N/A

Current Price

$64.20

Market Cap

3.2B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
AMRX
CNS
Founded
2002
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.2B
IPO Year
2018
2004

Fundamental Metrics

Financial Performance
Metric
AMRX
CNS
Price
$13.20
$64.20
Analyst Decision
Strong Buy
Hold
Analyst Count
4
2
Target Price
$14.75
$72.50
AVG Volume (30 Days)
1.6M
246.5K
Earning Date
05-15-2026
04-23-2026
Dividend Yield
N/A
4.13%
EPS Growth
157.89
N/A
EPS
0.22
2.97
Revenue
N/A
$427,536,000.00
Revenue This Year
$6.40
$7.83
Revenue Next Year
$6.54
$11.02
P/E Ratio
$60.25
$21.89
Revenue Growth
N/A
4.07
52 Week Low
$6.69
$58.39
52 Week High
$15.42
$85.86

Technical Indicators

Market Signals
Indicator
AMRX
CNS
Relative Strength Index (RSI) 34.52 42.60
Support Level $12.50 $63.76
Resistance Level $13.49 $64.43
Average True Range (ATR) 0.42 2.28
MACD -0.21 -0.25
Stochastic Oscillator 14.89 42.05

Price Performance

Historical Comparison
AMRX
CNS

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About CNS Cohen & Steers Inc

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for around two thirds of its $90.9 billion in managed assets at the end of September 2025. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (26%) of its managed assets (base management fees) from institutional clients, 48% (54%) from open-end funds, and 13% (20%) from closed-end funds.

Share on Social Networks: